PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
3.77%
Net income growth under 50% of META's 15.77%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
7.11%
D&A growth well above META's 1.03%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-390.00%
Negative yoy deferred tax while META stands at 124.68%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
23.75%
SBC growth well above META's 1.74%. Michael Burry would flag major dilution risk vs. competitor’s approach.
30.02%
Slight usage while META is negative at -33.52%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
66.23%
AR growth well above META's 48.58%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
45.40%
Some inventory rise while META is negative at -99.40%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
856.25%
AP growth well above META's 143.90%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-63.27%
Both reduce yoy usage, with META at -100.56%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-256.10%
Both negative yoy, with META at -33.33%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
7.95%
Operating cash flow growth at 50-75% of META's 11.85%. Martin Whitman would worry about lagging operational liquidity vs. competitor.
-20.30%
Both yoy lines negative, with META at -10.05%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-563.16%
Both yoy lines negative, with META at -221.05%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-0.83%
Both yoy lines negative, with META at -18.80%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-16.00%
We reduce yoy sales while META is 129.55%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-1662.26%
Both yoy lines negative, with META at -80.49%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-81.86%
We reduce yoy invests while META stands at 37.30%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
73.70%
Debt repayment growth of 73.70% while META is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Buyback growth of 100.00% while META is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.